Phase 1 Study of Intravaginal KB15A
Part of paid clinical trials in Norfolk, Virginia.
- Sponsor
- ZabBio Inc.
- Study ID
- NCT07222020
- Phase
- PHASE1
- Status
- Recruiting
Conditions
- Healthy Subjects
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 45 Years
- Healthy Volunteers
- Accepted
Interventions
- KB15A Vaginal Film — DRUGKB15A is a polyvinyl-alcohol based intravaginal film containing the KB15A.16.2 monoclonal antibody.
- Placebo Vaginal Film — DRUGThe Placebo is a polyvinyl-alcohol based intravaginal film composed identically to the KB15A Vaginal Film, but without the KB15A.16.2 monoclonal antibody.
Study Details
The goal of this clinical trial is to determine the safety and mucosal pharmacokinetics of KB15A, a vaginal film containing an anti-sperm monoclonal antibody, in healthy adult women. Researchers will compare KB15A use to placebo use, primarily to see if KB15A is associated with adverse events, and also to understand the local and systemic distribution of the KB15A monoclonal antibody following use of the vaginal film. Participants will be assessed for the genital, mucosal and systemic safety and pharmacokinetics of KB15A in a preliminary single-dose phase of the study, where they will receive two single doses of either KB15A or placebo vaginal film, and again in a multiple-dose phase of the study, where they will receive 14 daily doses of either KB15A or placebo vaginal film.
Key Dates
- Start date
- Jan 1, 2026
- Status verified
- Dec 2025
- Primary completion
- Sep 1, 2026
- Completion
- Dec 28, 2026
Study Design
- Enrollment
- 24 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Experimental: KB15AKB15A (Vaginal Film)
- Placebo Comparator: PlaceboPlacebo (Vaginal Film)
Primary Outcome Measure
Treatment Emergent Adverse Events (TEAEs) and relatedness of TEAEs to study product or study procedures. [ Time Frame: From baseline through study completion, on average 3-4 months ]
Central Contacts
- Kristin Ayers757-446-0529
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Virginia Health Sciences at Old Dominion University | Norfolk | Virginia | 23507 | - |
Find similar trials in Norfolk, VA
Related Studies
- Optimizing Ultrasound-induced Anti-inflammation in Human SubjectsRecruiting · University of Virginia · Charlottesville, Virginia
- A Recovery and Lifespan Study Using INTERCEPT Red Blood Cells Prepared Using the INTERCEPT Blood System for RBCs With AS-1PHASE2 · Recruiting · Cerus Corporation · Cincinnati, Ohio
- Oral Bacteria and Immune System Problems Involved in Gum Disease (Periodontitis)Recruiting · National Institute of Dental and Craniofacial Research (NIDCR) · Bethesda, Maryland
- Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR)Recruiting · National Heart, Lung, and Blood Institute (NHLBI) · Bethesda, Maryland